Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The general interactive model described in the previous paper was subjected to experimental testing. We examined the high affinity anti-TNP plaque-forming cell response of cultures of murine lymphocytes exposed to
lipopolysaccharide
and trinitrophenylated
lipopolysaccharide
(TNP--LPS). From our model we predicted the effects of the addition of free LPS on the dose response to TNP--LPS, the effect of the addition of
Polymyxin B
to cultures stimulated with TNP--LPS, and the effect on the response to TNP--LPS preparations with different haptenation ratios. The results obtained were consistent with the predictions of the general interactive model.
...
PMID:A general interactive model for B cell activation II. Experimental verification. 616 64
The outer membrane-disorganizing effect of a short (10-min) treatment with polycationic agents was studied with smooth Salmonella typhimurium used as a test organism. The polycationic agents were the protamine salmine, a lysine polymer with 20 lysine residues (lysine20), and the deacylated polymyxin B derivative polymyxin B nonapeptide. Two different types of outer membrane-disorganizing were found. Protamine and lysine20 released 20 to 30% of the
lipopolysaccharide
from the outer membrane and sensitized the bacteria to the anionic detergent sodium dodecyl sulfate but did not (under these conditions) make the bacteria permeable to the hydrophobic probes fusidic acid and actinomycin D. In contrast, polymyxin B nonapeptide did not release
lipopolysaccharide
or sensitize the bacteria to sodium dodecyl sulfate but made the outer membrane permeable to the hydrophobic probes. None of the agents was bactericidal under the conditions used or caused any leakage of periplasmic beta-lactamase.
Polymyxin B
was used as a reference and showed characteristic outer membrane-disorganizing action. In thin-section electron microscopy, polymyxin B nonapeptide caused the appearance of long, narrow, finger-like projections on the outer membrane. Protamine and lysine20 caused a distinctly wrinkled appearance of the outer membrane but no projections.
...
PMID:Polycations as outer membrane-disorganizing agents. 619 43
A sensitive hapten-sandwich immunofluorescence technique was used to examine binding of
lipopolysaccharide
(
LPS
) at the single-cell level. The structural features governing such binding to murine lymphocytes were investigated by evaluating
LPS
binding in the presence of a variety of charged molecules and after different target-cell treatments.
Polymyxin B
, the positively charged proteins egg-white lysozyme and protamine chloride, and the polyanion dextran sulfate inhibited
LPS
binding to murine lymphocytes. Pretreatment with the proteolytic enzyme pronase and the cross-linking agent paraformaldehyde abolished the capacity of lymphocytes to bind
LPS
. Inhibition by polymyxin B was less effective when added 30 min after initiation of incubation of
LPS
with cells at 0 C or when added at the initiation of incubation at 37 C. These results suggest that the interaction between
LPS
and lymphocytes is a two-stage process, the first of which is dependent on a positively charged membrane protein. The second stage is postulated to be an irreversible hydrophobic interaction between
LPS
and membrane lipids.
...
PMID:Structural features of binding of lipopolysaccharides to murine lymphocytes. 620 43
Endotoxin activity in suspensions of Bordetella pertussis, Escherichia coli, Haemophilus influenzae, and Pseudomonas aeruginosa was often markedly decreased by polymyxin B.
Polymyxin B
treatment may be a means to reduce inflammatory reactivity of
lipopolysaccharide
in vaccines of gram-negative bacteria.
...
PMID:Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria. 626 67
The lectin agglutinability of human erythrocytes has been utilized to examine interactions of gram-negative endotoxin with mammalian cell plasma membranes. Erythrocytes treated in buffer with Escherichia coli 0127:B8
lipopolysaccharide
(
LPS
) or Salmonella minnesota Re595 glycolipid for 1 h became resistant to agglutination by the lectin concanavalin A (ConA) in buffer free of
LPS
or glycolipid.
Polymyxin B
, a cationic cyclic lipopeptide which specifically binds to the lipid A toxophore, was tested for possible effects on the
LPS
and glycolipid inhibition of Con A erythrocyte agglutination. The presence of polymyxin B during the initial 1-h treatment with
LPS
or glycolipid blocked the ability of the endotoxins to render erythrocytes refractory to agglutination by ConA. Inhibition by polymyxin B was stoichiometric, and in repeated experiments,
LPS
was completely suppressed in the hemagglutination assay at a polymyxin B:
LPS
weight ratio of 1:4.1 (increasing polymyxin concentration, constant
LPS
concentration) and 1:5.1 (constant polymyxin concentration, increasing
LPS
concentration). These stoichiometry values are similar to values obtained for inhibition by polymyxin B of
LPS
lymphoid cell activation. It was concluded, therefore, that endotoxin inhibition of ConA erythrocyte agglutination reflects interactions of erythrocyte membranes with the lipid A region of endotoxin. In addition, the stoichiometry of polymyxin B inhibition suggests a similar extent of lipid A-dependent
LPS
interaction with erythrocytes and lymphoid cells.
...
PMID:Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination. 627 6
The inability to prepare an effective polysaccharide vaccine against group B Neisseria meningitidis was the impetus for these studies. Outer membrane protein vaccines used in our initial studies failed to induce bactericidal antibodies in humans. The particulate nature of these vaccines may have led to their clearance before effective immune stimulation. Less denaturing procedures, therefore, were developed for preparation of serotype 2 protein-containing vaccines. These procedures included isolation of naturally released outer membrane vesicles and selective removal of
lipopolysaccharide
from the vesicles by the nonionic detergent Brij-96. The resultant protein vaccines were evaluated with and without noncovalently complexed group B meningococcal polysaccharide or polymyxin B sulfate or both. The new vaccines were at least 10-fold more immunogenic in mice and guinea pigs than the previous vaccines when assayed for bactericidal and enzyme-linked immunosorbent assay antibodies. The protein vaccines alone protected guinea pigs from intrachamber infection, and a single 0.1-microgram injection prevented meningococcal bacteremia in mice. Addition of group B polysaccharide to the protein significantly improved the immunogenicity of the protein, and this combined vaccine showed a greater protective effect.
Polymyxin B
generally reduced the immunogenicity of the vaccines in both mice and guinea pigs.
...
PMID:Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations. 680 28
We have previously reported a method of mast cell induction by long-term culture of mouse spleen cells without using exogenous mast cell growth factor (Z.-Q. Hu, T. Yoshida, and T. Shimamura, J. Immunol. Methods 149:173, 1992). Supernatants recovered from the long-term cultures contain endogenous interleukin 3 and soluble stem cell factor. These were assessed by the capacity of the recovered supernatants to foster the growth of a mast cell growth factor-dependent cell line and by neutralizing antibodies. Besides the soluble factors, cell-to-cell contacts mediated by membrane stem cell factor on splenic stromal cells and c-Kit receptors on mast cells also affect mast cell induction. Different lots of fetal calf serum (FCS) were examined to determine a possible trigger for cytokine production. FCS can be divided into mast cell-inducible and noninducible sera by this process. However, not all FCS lots contain mast cell growth factor. The mast cell-inducible lots contain
lipopolysaccharide
(
LPS
) confirmed by a Limulus assay.
Polymyxin B
can neutralize the mast cell induction activity. Non-mast cell-inducible FCS can be converted to inducible FCS by adding exogenous
LPS
. The results indicate that
LPS
as a trigger of cytokine production is responsible for mast cell induction.
...
PMID:Effect of lipopolysaccharide on mouse mast cell induction by a splenic cell culture system. 752 Apr 22
The rough-form
lipopolysaccharide
(
LPS
) interacted with cationic antibiotic polymyxin B and gramicidin S in solution, and showed altered thermotropic phase behavior and viscoelasticity. The phase behavior was measured by differential scanning calorimetry and quartz crystal microbalance (QCM). Addition of polymyxin B of up to 0.5 mg/mL to the 5.0 mg/mL
LPS
solution increased gel-to-liquid crystalline phase transition enthalpy (delta H) and raised the transition temperature (tmax). The further addition of polymyxin B reduced the delta H value. Gramicidin S produced a different effect, whereby a minor addition reduced tmax and delta H value of the
LPS
. The
LPS
film on the platinum electrode of the QCM indicated a downward shift of resonant frequency and an upward shift of resonant resistance when in contact with the antibiotic solution. An interpretation of these variations is that the
LPS
on the QCM electrode changed not only film weight, but also viscoelasticity owing to contact with the antibiotic solution. The different effects between the antibiotics between polymyxin B and gramicidin S on the
LPS
are induced by the difference of the governing effect.
Polymyxin B
interacts with the
LPS
electrostatically, whereas gramicidin S interacts by hydrophobic moieties.
...
PMID:Influence of cationic antibiotics on phase behavior of rough-form lipopolysaccharide. 752 97
Taxol, a microtubule stabilizer with anticancer activity, mimics the actions of
lipopolysaccharide
(
LPS
) on murine macrophages in vitro. Recently, it was shown that taxol-induced macrophage activation was inhibited by the
LPS
antagonist Rhodobacter sphaeroides diphosphoryl lipid A (RsDPLA). To investigate the mechanisms of taxol-induced macrophage activation, the present study focused on the interaction of
LPS
, RsDPLA, and taxol in the activation of and binding to macrophages. Taxol alone induced murine C3H/He macrophages to secrete tumor necrosis factor alpha (TNF) and to produce nitric oxide (NO) with kinetics similar to that of
LPS
. Macrophages from
LPS
-hyporesponsive C3H/HeJ mice, in contrast, did not yield any detectable TNF and NO production in response to
LPS
or taxol. RsDPLA inhibited taxol-induced TNF and NO production from C3H/He macrophages in a dose-dependent manner. The inhibition by RsDPLA was specific for
LPS
and taxol in that RsDPLA did not inhibit heat-killed Listeria monocytogenes- or zymosan-induced TNF production.
Polymyxin B
blocked the inhibitory effect of RsDPLA on taxol-induced TNF production. The inhibitory activity of RsDPLA appeared to be reversible since macrophages still responded to taxol in inducing TNF production after the RsDPLA was washed out with phosphate-buffered saline prior to the addition of taxol. Taxol-induced TNF production was not inhibited by colchicine, vinblastine, or 10-deacetylbaccatine III. A mutant cell line, J7.DEF3, defective in expression of a CD14 antigen, responded equally well to taxol by producing TNF as did the parent J774.1 cells. This suggested that the activation of macrophages by taxol does not require CD14. Taxol-induced TNF production by the mutant cells was also inhibited by RsDPLA. 125I-labeled
LPS
and 3H-labeled taxol was reported to bind to J774.1 cells predominantly via CD14 and microtubules, respectively. The binding of 125I-labeled
LPS
to J7.DEF3 cells was about 30 to 40% of that to J774.1 cells. The binding of 125I-
LPS
to J774.1 cells was inhibited by unlabeled
LPS
and RsDPLA but not by taxol. On the other hand, 3H-labeled taxol bound to both J774.1 cells and J7.DEF3 cells in similar time- and dose-dependent manners. The binding of [3H]taxol to these cells was inhibited by taxol but not by
LPS
or RsDPLA. Although the binding studies failed to examine cross competition for binding to macrophages, a possible explanation of these results is that
LPS
, RsDPLA, and taxol share the same molecule(s) on murine macrophages for their functional receptor(s), which is neither CD14 nor tubulin.
...
PMID:CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. 752 46
In human monocytes, superoxide (O2-) generation accompanies phagocytosis and is important for bactericidal activity. It also contributes to tissue damage in inflammation. In the present study we investigated, whether
lipopolysaccharide
(
LPS
) directly stimulates monocyte O2- production with kinetics known for other
LPS
effects and, if so, by which mechanism.
LPS
caused a time- and dose-dependent O2- release in nonadherent purified monocytes. The effect appeared after 5 min, peaked at 30 min, and disappeared after 2 h. It was maximal with 10 ng/ml lipid A (+148 +/- 22%, P < .001), 1 ng/ml
LPS
Escherichia coli Re (+226 +/- 68%, P < .001), and 100 ng/ml
LPS
Salmonella abortus equi sm (+272 +/- 52%, P < .001), respectively. The effect was not observed in buffer, even when using 10 micrograms/ml
LPS
. It was dependent on the presence of heat-inactivated AB serum, with a maximal effect at > or = 0.5%. Serum could be replaced by LPS-binding protein (LBP).
Polymyxin B
and anti-LBP antiserum, respectively, blocked the
LPS
effect.
LPS
-induced O2- generation was also completely blocked by anti-CD14 antibodies (3C10 and 63D3) and by their corresponding F(ab')2 fragments. Monocytes treated with phosphoinositol-specific phospholipase C and monocytes from patients with paroxysmal nocturnal hemoglobinuria, lacking the phosphatidylinositol-anchored CD14, did not respond to
LPS
stimulation with O2- production. Similarly to
LPS
, E. coli caused stronger O2- production with heat-inactivated serum than without, and this effect was blocked by anti-CD14 antibodies. In conclusion, these data indicate that
LPS
directly stimulates O2- production in human monocytes via CD14 depending on LBP.
...
PMID:LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14. 753 19
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>